OUP is a venture capital fund investing in start-ups that commercialize university research.
Osage University Partners is a venture capital firm focused on investing in startups that are commercializing university technologies. Osage partners with research universities to invest in their innovative startups shareing its investment profit with partner institutions. The firm invests in software, hardware, and life science companies at all stages of company development. To date, it has partnered with over 80 universities, including 36 of the top 50 U.S. institutions by research expenditures, and has invested in over 50 of their spinouts.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |
Sep 2, 2021
Corelight
|
Series D | $75M | Analytics | — |
Nov 12, 2020
Menlo Security
|
Series E | $100M | Cyber Security | — |
Jul 7, 2020
Vor Biopharma
|
Series B | $110M | Biotechnology | — |
Mar 26, 2020
ReCode Therapeutics
|
Series A | $80M | Biopharma | — |